poweruser
https://www.bioeconomy.tw/wp-content/uploads/2025/11/logo-2025.webp
poweruser2026-03-10 23:02:082026-03-10 23:12:37台經社談生物經濟：次世代生物創新 從技術突破走向商業價值
poweruser
https://www.bioeconomy.tw/wp-content/uploads/2025/11/logo-2025.webp
poweruser2026-03-06 00:04:422026-03-06 00:04:42台經社倡議「生物經濟 」 G20全球發展藍圖與下一波永續經濟轉型
poweruser
https://www.bioeconomy.tw/wp-content/uploads/2025/11/logo-2025.webp
poweruser2026-02-24 13:46:432026-02-24 21:49:20自然資本投資秩序重塑 生物多樣性金融成國際治理關鍵
poweruser
https://www.bioeconomy.tw/wp-content/uploads/2025/11/logo-2025.webp
poweruser2026-02-12 09:42:542026-02-12 14:03:34台經社倡議 建構自然正向與生物多樣性信用市場機制
poweruser
https://www.bioeconomy.tw/wp-content/uploads/2025/11/logo-2025.webp
poweruser2026-02-05 09:41:072026-02-05 14:14:08孫智麗分析 從巴菲特指數看AI投資浪潮下評價的經濟學邏輯
poweruser
https://www.bioeconomy.tw/wp-content/uploads/2025/11/logo-2025.webp
poweruser2026-01-28 10:28:472026-01-28 10:28:47台經社分析 Netflix直播獨攀台北101之行銷策略與效益評估
poweruser
https://www.bioeconomy.tw/wp-content/uploads/2025/11/logo-2025.webp
poweruser2026-01-23 18:22:442026-01-23 21:08:40台經社分析 川普大健保計畫、藥價平台(TrumpRx)及GLP-1藥價
poweruser
https://www.bioeconomy.tw/wp-content/uploads/2025/11/logo-2025.webp
poweruser2026-01-13 10:24:142026-01-13 10:56:49孫智麗社長：生醫研發成果評價原理及方法
